---
title: "Roxatidine Acetate - Zollinger-Ellison Syndrome"
sidebar: mydoc_sidebar
permalink: db08806-mesh-d015043-1.html
toc: false 
---


Path ID: `DB08806_MESH_D015043_1`
{% include image.html url="images/db08806-mesh-d015043-1.png" file="db08806-mesh-d015043-1.png" alt="db08806-mesh-d015043-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C053742 | Roxatidine acetate | Drug |
| UniProt:P25021 | Histamine H2 receptor | Protein |
| GO:0001696 | Gastric acid secretion | BiologicalProcess |
| MESH:D005744 | Gastric Acid | ChemicalSubstance |
| InterPro:IPR034162 | Pepsin catalytic domain | GeneFamily |
| HP:0004398 | Peptic ulcer | PhenotypicFeature |
| MESH:D015043 | Zollinger-Ellison syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Roxatidine Acetate | DECREASES ACTIVITY OF | Histamine H2 Receptor |
| Histamine H2 Receptor | POSITIVELY REGULATES | Gastric Acid Secretion |
| Gastric Acid Secretion | INCREASES ABUNDANCE OF | Gastric Acid |
| Gastric Acid | POSITIVELY REGULATES | Pepsin Catalytic Domain |
| Pepsin Catalytic Domain | CONTRIBUTES TO | Peptic Ulcer |
| Peptic Ulcer | MANIFESTATION OF | Zollinger-Ellison Syndrome |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08806#BE0000112](https://go.drugbank.com/drugs/DB08806#BE0000112)
